TRAVIS WEISS: Open Payments
NPI 1699084814 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 54 payments from 16 companies in 2025. Trend: 2023 $929 · 2024 $899 · 2025 $1,041
Food & beverage: $1,022Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $271 |
| Phathom Pharmaceuticals, Inc. | 2 | $143 |
| AstraZeneca Pharmaceuticals LP | 8 | $143 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $87 |
| Lilly USA, LLC | 3 | $58 |
| Viatris Specialty LLC | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Novo Nordisk Inc | 2 | $41 |
| Lundbeck LLC | 2 | $39 |
| Amgen Inc. | 2 | $39 |
Products named: VRAYLAR, VOQUEZNA, BREZTRI, JARDIANCE, REXULTI, YUPELRI, Ozempic, MOUNJARO.
Industry payments across MO — which companies pay providers there.
